Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 89 | 35 | 19 | 31 | 65 |
| Cost of Goods | 7 | N/A | N/A | N/A | N/A |
| Gross Profit | 83 | 35 | 19 | 31 | 65 |
| Operating Expenses | 2,558 | 4,144 | 3,240 | 3,135 | 3,181 |
| Operating Income | -2,469 | -4,109 | -3,221 | -3,104 | -3,117 |
| Interest Expense | -176 | -163 | -376 | -62 | -96 |
| Other Income | -1,736 | 1,723 | 541 | 7,811 | -2,689 |
| Pre-tax Income | -4,029 | -2,223 | -2,304 | 4,768 | -5,709 |
| Net Income Continuous | -4,029 | -2,223 | -2,304 | 4,768 | -5,709 |
| Net Income | $-4,029 | $-2,223 | $-2,304 | $4,768 | $-5,709 |
| EPS Basic Total Ops | -0.50 | -0.33 | -0.11 | 1.04 | -1.47 |
| EPS Basic Continuous Ops | -0.50 | -0.33 | -0.11 | 1.04 | -1.47 |
| EPS Diluted Total Ops | -0.50 | -0.33 | 0.54 | 0.39 | -1.47 |
| EPS Diluted Continuous Ops | -0.50 | -0.33 | 0.54 | 0.39 | -1.47 |
| EPS Diluted Before Non-Recurring Items | -0.50 | -0.53 | -0.57 | N/A | N/A |
| EBITDA(a) | $-2,421 | $-4,067 | $-3,178 | $-3,062 | $-3,075 |